Advanced Use of Toxin Binders and Cholegogues in Detoxification Protocols (Chiropractic Continuing Ed Track registrants only)
Advanced Use of Toxin Binders and Cholegogues in Detoxification Protocols
Proper movement of toxins through the liver is intimately tied to bile movement. Endotoxin and certain mycotoxins are common examples of toxins that can cause intrahepatic cholestasis (blocked flow of bile from the hepatocyte to bile tree). This also blocks toxin flow to the GI tract and results in toxins and bile salts being exported to the blood. This is the cause of most “detox reactions” experienced during attempts at detoxification. The two most common aspects of successful detoxification missed by detox programs are: 1) matching liver detoxification upregulation to bile flow, and 2) binding toxins once they get to the GI tract so that they are not reabsorbed. Failing to support bile transport and the resulting “back-fire” into the blood can cause or exacerbate neurological symptoms, kidney stress, or skin eruptions. On the other hand, failing to absorb the toxins onto solid binders in the GI tract allow the toxins to poison the GI tract and/or reabsorb into circulation, with similar symptom aggravation listed above for bile stagnation. Despite the importance of “binders”, different binder types and functionality are generally very poorly understood in integrative and functional medicine. This lecture will outline the major types of binders and what classes of chemicals they work for, how to combine them, and how to keep liver detoxification reactions balanced with bile flow.
Christopher Shade, PhD
Christopher Shade, PhD, earned a PhD from the University of Illinois, where he studied the environmental and analytical chemistries of mercury as well as advanced aquatic chemistry. During his PhD work, Dr. Shade patented analytical technology for mercury speciation analysis and later founded Quicksilver Scientific, LLC, in order to commercialize this technology. Shortly after starting Quicksilver Scientific, Dr. Shade turned his focus to the human aspects of mercury exposure/toxicity and the human detoxification system. He has since developed a system of products to remove metallic and organic toxins by upregulation of innate detoxification biochemistry. He has also focused on development of advanced phospholipid-based delivery systems for nutraceuticals.
